Verastem, Inc. (NASDAQ:VSTM) Q3 2025 Earnings Call Transcript November 4, 2025
Verastem, Inc. misses on earnings expectations. Reported EPS is $-1.35 EPS, expectations were $-0.51.
Operator: Good morning, and welcome to Verastem Oncology’s Third Quarter 2025 Earnings Conference Call. My name is Liz, and I’ll be your call operator for today. Please note, this event is being recorded. [Operator Instructions] I will now turn the call over to Julissa Viana, Vice President of Corporate...
